首頁 > 市場調查報告書 > 電子零件/半導體

感測器

市場調查報告書

商品編碼

1762884

2025-2029年全球製藥業CMO市場

Global CMO Market in Pharmaceutical Industry 2025-2029

出版日期: 2025年06月28日 | 出版商:

TechNavio | 英文 208 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計2024年至2029年，醫藥CMO市場規模將達4,270萬美元，預測期間內複合年成長率為6.5%。本報告對醫藥CMO市場進行了全面分析，包括市場規模及預測、趨勢、成長動力以及對約25家供應商的分析。

它提供了對當前市場情景、最新趨勢和促進因素以及整體市場環境的最新分析。新興市場中具有成本效益的資源的可用性、對核心競爭力的日益關注以及強大的研究資金推動著市場的發展。

市場覆蓋
基準年	2025
年底	2029
預測期	2025-2029
成長動力	加速度
同比	6%
複合年成長率	6.5%
增量金額	4270萬美元

這項研究客觀地結合了一手和二手訊息，並參考了行業主要參與者的意見。報告包含全面的市場規模數據、區域細分分析、供應商格局以及對主要企業的分析。報告同時包含歷史數據和預測數據。

研究指出，美國FDA 批准的製造設施是推動未來幾年製藥業 CMO 市場成長的主要原因之一，而新製造合約數量的增加和巨量資料的出現將導致市場需求龐大。

地理細分
區域比較
歐洲：2024-2029 年市場規模及預測
北美：2024-2029 年市場規模及預測
亞太地區：2024-2029 年市場規模及預測
中東和非洲：2024-2029 年市場規模及預測
南美洲：2024-2029 年市場規模及預測
美國：市場規模及預測（2024-2029）
德國：2024-2029年市場規模及預測
中國：2024-2029年市場規模及預測
法國：2024-2029年市場規模及預測
加拿大：市場規模及預測（2024-2029）
英國：2024-2029 年市場規模及預測
義大利：2024-2029 年市場規模及預測
西班牙：2024-2029 年市場規模及預測
日本：2024-2029 年市場規模及預測
印度：2024-2029 年市場規模及預測
按地區分類的市場機會

第13章促進因素、挑戰、機會與限制因素

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機會與限制

第14章競爭格局

概述
競爭格局
令人困惑的情況
產業風險

第15章競爭分析

公司簡介
企業排名指數
公司市場定位
Almac Group Ltd.
Boehringer Ingelheim International GmbH
Cadila Pharmaceuticals Ltd.
Cambrex Corp.
Catalent Inc.
Cipla Inc.
Cmic Holdings Co. Ltd
Curia Global Inc.
Dr Reddys Laboratories Ltd.
FAMAR Health Care Services
Jubilant Pharma Ltd.
Lonza Group Ltd.
Lupin Ltd.
Pfizer Inc.
Thermo Fisher Scientific Inc.

第16章附錄

簡介目錄圖表

Product Code: IRTNTR71566

The cmo in pharmaceutical industry market is forecasted to grow by USD 42.7 mn during 2024-2029, accelerating at a CAGR of 6.5% during the forecast period. The report on the cmo in pharmaceutical industry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of cost-efficient resources in emerging markets, growing need to focus on core competencies, and strong research funding.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6%
CAGR	6.5%
Incremental Value	$42.7 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's cmo in pharmaceutical industry market is segmented as below:

By Service

API manufacturing
FDF manufacturing

By Drug Class

Small molecule
Drugs biologics
High potency drugs

By End-user

Big pharma
Small and medium enterprises (SMEs)
Generic drug manufacturers
Biotech companies

By Geographical Landscape

Europe
North America
APAC
Middle East and Africa
South America

This study identifies the us fda-approved manufacturing facilities as one of the prime reasons driving the cmo in pharmaceutical industry market growth during the next few years. Also, increasing number of contracts for manufacturing novel and advent of big data will lead to sizable demand in the market.

The report on the cmo in pharmaceutical industry market covers the following areas:

CMO In Pharmaceutical Industry Market sizing
CMO In Pharmaceutical Industry Market forecast
CMO In Pharmaceutical Industry Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cmo in pharmaceutical industry market vendors that include Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Cambrex Corp., Catalent Inc., Chongqing Huapont Pharmaceutical Co. Ltd., Cipla Inc., Cmic Holdings Co. Ltd, Curia Global Inc., Dr Reddys Laboratories Ltd., FAMAR Health Care Services, Jubilant Pharma Ltd., Lonza Group Ltd., Lupin Ltd., PCI Pharma Services, Pfizer Inc., Recipharm AB, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., and Vetter Pharma Fertigung GmbH and Co. KG. Also, the cmo in pharmaceutical industry market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Service
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global CMO Market In Pharmaceutical Industry 2019 - 2023
- Historic Market Size - Data Table on Global CMO Market In Pharmaceutical Industry 2019 - 2023 ($ million)
5.2 Service segment analysis 2019 - 2023
- Historic Market Size - Service Segment 2019 - 2023 ($ million)
5.3 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on global CMO market in pharmaceutical industry

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Service

8.1 Market segments
- Chart on Service - Market share 2024-2029 (%)
- Data Table on Service - Market share 2024-2029 (%)
8.2 Comparison by Service
- Chart on Comparison by Service
- Data Table on Comparison by Service
8.3 API manufacturing - Market size and forecast 2024-2029
- Chart on API manufacturing - Market size and forecast 2024-2029 ($ million)
- Data Table on API manufacturing - Market size and forecast 2024-2029 ($ million)
- Chart on API manufacturing - Year-over-year growth 2024-2029 (%)
- Data Table on API manufacturing - Year-over-year growth 2024-2029 (%)
8.4 FDF manufacturing - Market size and forecast 2024-2029
- Chart on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
- Data Table on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
- Chart on FDF manufacturing - Year-over-year growth 2024-2029 (%)
- Data Table on FDF manufacturing - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Service
- Market opportunity by Service ($ million)
- Data Table on Market opportunity by Service ($ million)

9 Market Segmentation by Drug Class

9.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
9.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
9.3 Small molecule - Market size and forecast 2024-2029
- Chart on Small molecule - Market size and forecast 2024-2029 ($ million)
- Data Table on Small molecule - Market size and forecast 2024-2029 ($ million)
- Chart on Small molecule - Year-over-year growth 2024-2029 (%)
- Data Table on Small molecule - Year-over-year growth 2024-2029 (%)
9.4 Drugs biologics - Market size and forecast 2024-2029
- Chart on Drugs biologics - Market size and forecast 2024-2029 ($ million)
- Data Table on Drugs biologics - Market size and forecast 2024-2029 ($ million)
- Chart on Drugs biologics - Year-over-year growth 2024-2029 (%)
- Data Table on Drugs biologics - Year-over-year growth 2024-2029 (%)
9.5 High potency drugs - Market size and forecast 2024-2029
- Chart on High potency drugs - Market size and forecast 2024-2029 ($ million)
- Data Table on High potency drugs - Market size and forecast 2024-2029 ($ million)
- Chart on High potency drugs - Year-over-year growth 2024-2029 (%)
- Data Table on High potency drugs - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

10 Market Segmentation by End-user

10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
10.3 Big pharma - Market size and forecast 2024-2029
- Chart on Big pharma - Market size and forecast 2024-2029 ($ million)
- Data Table on Big pharma - Market size and forecast 2024-2029 ($ million)
- Chart on Big pharma - Year-over-year growth 2024-2029 (%)
- Data Table on Big pharma - Year-over-year growth 2024-2029 (%)
10.4 Small and medium enterprises (SMEs) - Market size and forecast 2024-2029
- Chart on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
- Data Table on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
- Chart on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
- Data Table on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
10.5 Generic drug manufacturers - Market size and forecast 2024-2029
- Chart on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
- Data Table on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
- Chart on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
- Data Table on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
10.6 Biotech companies - Market size and forecast 2024-2029
- Chart on Biotech companies - Market size and forecast 2024-2029 ($ million)
- Data Table on Biotech companies - Market size and forecast 2024-2029 ($ million)
- Chart on Biotech companies - Year-over-year growth 2024-2029 (%)
- Data Table on Biotech companies - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.4 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.5 APAC - Market size and forecast 2024-2029
- Chart on APAC - Market size and forecast 2024-2029 ($ million)
- Data Table on APAC - Market size and forecast 2024-2029 ($ million)
- Chart on APAC - Year-over-year growth 2024-2029 (%)
- Data Table on APAC - Year-over-year growth 2024-2029 (%)
12.6 Middle East and Africa - Market size and forecast 2024-2029
- Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
- Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
- Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
12.7 South America - Market size and forecast 2024-2029
- Chart on South America - Market size and forecast 2024-2029 ($ million)
- Data Table on South America - Market size and forecast 2024-2029 ($ million)
- Chart on South America - Year-over-year growth 2024-2029 (%)
- Data Table on South America - Year-over-year growth 2024-2029 (%)
12.8 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.15 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ million)
- Data Table on Spain - Market size and forecast 2024-2029 ($ million)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.16 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.17 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.18 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Almac Group Ltd.
- Almac Group Ltd. - Overview
- Almac Group Ltd. - Product / Service
- Almac Group Ltd. - Key offerings
- SWOT
15.5 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
15.6 Cadila Pharmaceuticals Ltd.
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- SWOT
15.7 Cambrex Corp.
- Cambrex Corp. - Overview
- Cambrex Corp. - Product / Service
- Cambrex Corp. - Key news
- Cambrex Corp. - Key offerings
- SWOT
15.8 Catalent Inc.
- Catalent Inc. - Overview
- Catalent Inc. - Business segments
- Catalent Inc. - Key offerings
- Catalent Inc. - Segment focus
- SWOT
15.9 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
15.10 Cmic Holdings Co. Ltd
- Cmic Holdings Co. Ltd - Overview
- Cmic Holdings Co. Ltd - Business segments
- Cmic Holdings Co. Ltd - Key offerings
- Cmic Holdings Co. Ltd - Segment focus
- SWOT
15.11 Curia Global Inc.
- Curia Global Inc. - Overview
- Curia Global Inc. - Product / Service
- Curia Global Inc. - Key offerings
- SWOT
15.12 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
15.13 FAMAR Health Care Services
- FAMAR Health Care Services - Overview
- FAMAR Health Care Services - Product / Service
- FAMAR Health Care Services - Key offerings
- SWOT
15.14 Jubilant Pharma Ltd.
- Jubilant Pharma Ltd. - Overview
- Jubilant Pharma Ltd. - Product / Service
- Jubilant Pharma Ltd. - Key offerings
- SWOT
15.15 Lonza Group Ltd.
- Lonza Group Ltd. - Overview
- Lonza Group Ltd. - Business segments
- Lonza Group Ltd. - Key news
- Lonza Group Ltd. - Key offerings
- Lonza Group Ltd. - Segment focus
- SWOT
15.16 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
15.17 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Service
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global CMO Market In Pharmaceutical Industry 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Service Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Service - Market share 2024-2029 (%)
Exhibits39: Data Table on Service - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Service
Exhibits41: Data Table on Comparison by Service
Exhibits42: Chart on API manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on API manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on API manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on API manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on FDF manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on FDF manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on FDF manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits50: Market opportunity by Service ($ million)
Exhibits51: Data Table on Market opportunity by Service ($ million)
Exhibits52: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits53: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits54: Chart on Comparison by Drug Class
Exhibits55: Data Table on Comparison by Drug Class
Exhibits56: Chart on Small molecule - Market size and forecast 2024-2029 ($ million)
Exhibits57: Data Table on Small molecule - Market size and forecast 2024-2029 ($ million)
Exhibits58: Chart on Small molecule - Year-over-year growth 2024-2029 (%)
Exhibits59: Data Table on Small molecule - Year-over-year growth 2024-2029 (%)
Exhibits60: Chart on Drugs biologics - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Drugs biologics - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Drugs biologics - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Drugs biologics - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on High potency drugs - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on High potency drugs - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on High potency drugs - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on High potency drugs - Year-over-year growth 2024-2029 (%)
Exhibits68: Market opportunity by Drug Class ($ million)
Exhibits69: Data Table on Market opportunity by Drug Class ($ million)
Exhibits70: Chart on End-user - Market share 2024-2029 (%)
Exhibits71: Data Table on End-user - Market share 2024-2029 (%)
Exhibits72: Chart on Comparison by End-user
Exhibits73: Data Table on Comparison by End-user
Exhibits74: Chart on Big pharma - Market size and forecast 2024-2029 ($ million)
Exhibits75: Data Table on Big pharma - Market size and forecast 2024-2029 ($ million)
Exhibits76: Chart on Big pharma - Year-over-year growth 2024-2029 (%)
Exhibits77: Data Table on Big pharma - Year-over-year growth 2024-2029 (%)
Exhibits78: Chart on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Small and medium enterprises (SMEs) - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Small and medium enterprises (SMEs) - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Generic drug manufacturers - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Generic drug manufacturers - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Biotech companies - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Biotech companies - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Biotech companies - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Biotech companies - Year-over-year growth 2024-2029 (%)
Exhibits90: Market opportunity by End-user ($ million)
Exhibits91: Data Table on Market opportunity by End-user ($ million)
Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits95: Chart on Geographic comparison
Exhibits96: Data Table on Geographic comparison
Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on APAC - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on APAC - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on APAC - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on APAC - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on South America - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on South America - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on South America - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on South America - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits154: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits155: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits157: Market opportunity By Geographical Landscape ($ million)
Exhibits158: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits159: Impact of drivers and challenges in 2024 and 2029
Exhibits160: Overview on criticality of inputs and factors of differentiation
Exhibits161: Overview on factors of disruption
Exhibits162: Impact of key risks on business
Exhibits163: Companies covered
Exhibits164: Company ranking index
Exhibits165: Matrix on companies position and classification
Exhibits166: Almac Group Ltd. - Overview
Exhibits167: Almac Group Ltd. - Product / Service
Exhibits168: Almac Group Ltd. - Key offerings
Exhibits169: SWOT
Exhibits170: Boehringer Ingelheim International GmbH - Overview
Exhibits171: Boehringer Ingelheim International GmbH - Product / Service
Exhibits172: Boehringer Ingelheim International GmbH - Key news
Exhibits173: Boehringer Ingelheim International GmbH - Key offerings
Exhibits174: SWOT
Exhibits175: Cadila Pharmaceuticals Ltd. - Overview
Exhibits176: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits177: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits178: SWOT
Exhibits179: Cambrex Corp. - Overview
Exhibits180: Cambrex Corp. - Product / Service
Exhibits181: Cambrex Corp. - Key news
Exhibits182: Cambrex Corp. - Key offerings
Exhibits183: SWOT
Exhibits184: Catalent Inc. - Overview
Exhibits185: Catalent Inc. - Business segments
Exhibits186: Catalent Inc. - Key offerings
Exhibits187: Catalent Inc. - Segment focus
Exhibits188: SWOT
Exhibits189: Cipla Inc. - Overview
Exhibits190: Cipla Inc. - Business segments
Exhibits191: Cipla Inc. - Key news
Exhibits192: Cipla Inc. - Key offerings
Exhibits193: Cipla Inc. - Segment focus
Exhibits194: SWOT
Exhibits195: Cmic Holdings Co. Ltd - Overview
Exhibits196: Cmic Holdings Co. Ltd - Business segments
Exhibits197: Cmic Holdings Co. Ltd - Key offerings
Exhibits198: Cmic Holdings Co. Ltd - Segment focus
Exhibits199: SWOT
Exhibits200: Curia Global Inc. - Overview
Exhibits201: Curia Global Inc. - Product / Service
Exhibits202: Curia Global Inc. - Key offerings
Exhibits203: SWOT
Exhibits204: Dr Reddys Laboratories Ltd. - Overview
Exhibits205: Dr Reddys Laboratories Ltd. - Business segments
Exhibits206: Dr Reddys Laboratories Ltd. - Key news
Exhibits207: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits208: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits209: SWOT
Exhibits210: FAMAR Health Care Services - Overview
Exhibits211: FAMAR Health Care Services - Product / Service
Exhibits212: FAMAR Health Care Services - Key offerings
Exhibits213: SWOT
Exhibits214: Jubilant Pharma Ltd. - Overview
Exhibits215: Jubilant Pharma Ltd. - Product / Service
Exhibits216: Jubilant Pharma Ltd. - Key offerings
Exhibits217: SWOT
Exhibits218: Lonza Group Ltd. - Overview
Exhibits219: Lonza Group Ltd. - Business segments
Exhibits220: Lonza Group Ltd. - Key news
Exhibits221: Lonza Group Ltd. - Key offerings
Exhibits222: Lonza Group Ltd. - Segment focus
Exhibits223: SWOT
Exhibits224: Lupin Ltd. - Overview
Exhibits225: Lupin Ltd. - Business segments
Exhibits226: Lupin Ltd. - Key news
Exhibits227: Lupin Ltd. - Key offerings
Exhibits228: Lupin Ltd. - Segment focus
Exhibits229: SWOT
Exhibits230: Pfizer Inc. - Overview
Exhibits231: Pfizer Inc. - Product / Service
Exhibits232: Pfizer Inc. - Key news
Exhibits233: Pfizer Inc. - Key offerings
Exhibits234: SWOT
Exhibits235: Thermo Fisher Scientific Inc. - Overview
Exhibits236: Thermo Fisher Scientific Inc. - Business segments
Exhibits237: Thermo Fisher Scientific Inc. - Key news
Exhibits238: Thermo Fisher Scientific Inc. - Key offerings
Exhibits239: Thermo Fisher Scientific Inc. - Segment focus
Exhibits240: SWOT
Exhibits241: Inclusions checklist
Exhibits242: Exclusions checklist
Exhibits243: Currency conversion rates for US$
Exhibits244: Research methodology
Exhibits245: Information sources
Exhibits246: Data validation
Exhibits247: Validation techniques employed for market sizing
Exhibits248: Data synthesis
Exhibits249: 360 degree market analysis
Exhibits250: List of abbreviations